Literature DB >> 22866154

Survivin promoter -31G/C polymorphism in oral cancer cell lines.

Salvatore de Maria1, Lorenzo Lo Muzio, Alessandra Braca, Paolo Rega, Amalia Cassano, Angela Vinella, Ruggiero Fumarulo, Rosario Serpico, Ernesto Farina, Vittoria Metafora, Giuseppe Pannone, Gian Pietro Ravagnan, Salvatore Metafora, Corrado Rubini, Maria Carteni, Maria Addolorata Mariggiò.   

Abstract

Survivin (SVV) is a protein that belongs to the inhibitor of apoptosis proteins (IAP) family and is involved in the G2/M phase progression of the cell cycle as a spindle‑associated molecule. The biological features of this protein are well documented and its activity appears to be involved in mitochondria-dependent and -independent antiapoptotic pathways. Overexpression of SVV at the transcriptional and translational level has been associated with cancer, a multifactorial disorder in which the occurrence of a -31G to C polymorphism in the promoter region may significantly contribute to the development of this pathology. To verify this hypothesis, the occurrence of a single nucleotide polymorphism (SNP) in cis-acting cell cycle-dependent elements (CDEs) and in cell cycle homology regions (CHRs) of the survivin TATA-less promoter was investigated. A total of 23 oral squamous cell carcinoma (OSCC) cell lines and normal epithelium-derived normal human epidermal keratinocyte (NHEK) cell lines were analyzed by RFLP and direct DNA sequencing of their promoter region. Furthermore, survivin expression at the transcriptional and translational levels was evaluated in these cells by RT-PCR and Western blotting, respectively. The findings indicate that the presence of a G or C allele is not directly correlated to survivin expression, at the mRNA or at the protein level, at least in the OSCC lines analyzed in this study.

Entities:  

Year:  2011        PMID: 22866154      PMCID: PMC3408009          DOI: 10.3892/ol.2011.358

Source DB:  PubMed          Journal:  Oncol Lett        ISSN: 1792-1074            Impact factor:   2.967


  21 in total

1.  Transcriptional analysis of human survivin gene expression.

Authors:  F Li; D C Altieri
Journal:  Biochem J       Date:  1999-12-01       Impact factor: 3.857

2.  The elusive factor Xa receptor: failure to detect transcripts that correspond to the published sequence of EPR-1.

Authors:  G J Zaman; E M Conway
Journal:  Blood       Date:  2000-07-01       Impact factor: 22.113

3.  Survivin gene-expression and splicing isoforms in oral squamous cell carcinoma.

Authors:  Salvatore De Maria; Giuseppe Pannone; Pantaleo Bufo; Angela Santoro; Rosario Serpico; Salvatore Metafora; Corrado Rubini; Daniela Pasquali; Silvana M Papagerakis; Stefania Staibano; Gaetano De Rosa; Ernesto Farina; Monica Emanuelli; Andrea Santarelli; Maria Ada Mariggiò; Lucio Lo Russo; Lorenzo Lo Muzio
Journal:  J Cancer Res Clin Oncol       Date:  2008-07-19       Impact factor: 4.553

4.  Survivin-deltaEx3 and survivin-2B: two novel splice variants of the apoptosis inhibitor survivin with different antiapoptotic properties.

Authors:  C Mahotka; M Wenzel; E Springer; H E Gabbert; C D Gerharz
Journal:  Cancer Res       Date:  1999-12-15       Impact factor: 12.701

5.  Molecular cloning of effector cell protease receptor-1, a novel cell surface receptor for the protease factor Xa.

Authors:  D C Altieri
Journal:  J Biol Chem       Date:  1994-02-04       Impact factor: 5.157

6.  [Correlation of -31G/C polymorphisms of survivin promoter to tumorigenesis of gastric carcinoma].

Authors:  Zheng-Jiang Cheng; Li-Hua Hu; Shao-Jun Huang
Journal:  Ai Zheng       Date:  2008-03

7.  Survivin -31G/C promoter polymorphism and sporadic colorectal cancer.

Authors:  Maria Gazouli; Nikolaos Tzanakis; George Rallis; George Theodoropoulos; Ioannis Papaconstantinou; Alkiviadis Kostakis; Nicholas P Anagnou; Nikolaos Nikiteas
Journal:  Int J Colorectal Dis       Date:  2008-10-23       Impact factor: 2.571

8.  Association between survivin gene promoter -31 C/G polymorphism and urothelial carcinoma risk in Taiwanese population.

Authors:  Yuan-Hung Wang; Hung-Yi Chiou; Chang-Te Lin; Hsiao-Yen Hsieh; Chia-Chang Wu; Cheng-Da Hsu; Cheng-Huang Shen
Journal:  Urology       Date:  2008-11-26       Impact factor: 2.649

9.  Characterization of a 500 kb region on 17q25 and the exclusion of candidate genes as the familial Tylosis Oesophageal Cancer (TOC) locus.

Authors:  Janet M Risk; Kathryn E Evans; Joanne Jones; Joanne E Langan; Lyn Rowbottom; Fiona E McRonald; Helen S Mills; Anthony Ellis; Joan M Shaw; Irene M Leigh; David P Kelsell; John K Field
Journal:  Oncogene       Date:  2002-09-12       Impact factor: 9.867

10.  Cell cycle regulation of the cyclin A, cdc25C and cdc2 genes is based on a common mechanism of transcriptional repression.

Authors:  J Zwicker; F C Lucibello; L A Wolfraim; C Gross; M Truss; K Engeland; R Müller
Journal:  EMBO J       Date:  1995-09-15       Impact factor: 11.598

View more
  3 in total

Review 1.  Oral epithelial stem cells - implications in normal development and cancer metastasis.

Authors:  Silvana Papagerakis; Giuseppe Pannone; Li Zheng; Imad About; Nawar Taqi; Nghia P T Nguyen; Margarite Matossian; Blake McAlpin; Angela Santoro; Jonathan McHugh; Mark E Prince; Petros Papagerakis
Journal:  Exp Cell Res       Date:  2014-05-05       Impact factor: 3.905

2.  Caspase-8 polymorphisms and risk of oral squamous cell carcinoma.

Authors:  Y I Tang; Yang Liu; Wei Zhao; Tao Yu; Haiyang Yu
Journal:  Exp Ther Med       Date:  2015-10-26       Impact factor: 2.447

3.  The prognostic significance of survivin expression in patients with HNSCC: a systematic review and meta-analysis.

Authors:  Liu-Qing Zhou; Yao Hu; Hong-Jun Xiao
Journal:  BMC Cancer       Date:  2021-04-17       Impact factor: 4.430

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.